NuScale Power Stock Rally, November 2026: Sector Rebound Drives 16.2% Gain as Q3 Discloses Doosan Production Deal

NuScale Power closed at $5.08, up 16.2% on November 6, 2026, as nuclear stocks broadly rebounded; no published report identifies a catalyst specific to NuScale, though Q3 disclosures filed the prior day stated the company had moved from development to physical production via a Doosan Enerbility fabrication agreement.

Nuclear energy stocks staged a broad recovery on November 6, 2026, with NuScale Power (NYSE: SMR) closing at $5.08, up 16.2% on the session. The move was sector-wide: Oklo rose 19% — driven, per published reports, by a narrower-than-expected quarterly loss — and Nano Nuclear Energy added 9%. No coverage item identifies a catalyst specific to NuScale beyond its participation in that broader rebound. The timing did coincide with the company having filed its Q3 2026 earnings disclosures — a 10-Q and an 8-K — with the SEC on November 5, the trading day prior.

That Q3 filing contained what the company characterized as a significant operational milestone. The 8-K stated that NuScale had signed an agreement with South Korea's Doosan Enerbility for fabrication of the upper reactor coolant system, which the company describes as the most complex and foundational component of its NuScale Power Module (NPM). The filing also stated explicitly that NuScale had progressed from development to physical production — language that marks a formal shift in a commercial timeline that has been long in the making. Doosan's involvement had already drawn market attention in October 2026, when news of the manufacturing arrangement lifted NuScale shares roughly 7%; the Q3 disclosure firms that agreement into the company's official earnings record.

NuScale's capital expenditure trajectory adds useful context to the physical-production claim. Slicast's compilation of SEC XBRL data shows capital expenditure reached $508K in FY2025, a 1,054.5% increase from $44K in FY2024, against $31M in revenue — a capex intensity of 2%. By the quarter ended March 31, 2026, the quarterly figure had reached $2M, the highest single quarter recorded in Slicast's data series dating to 2020. Even so, NuScale ranks last by both absolute capex and capital intensity within the eight-company power peer group tracked here — Vistra leads on intensity, Constellation Energy on absolute spend. These figures reflect a company still in early-stage commercialization, making the Doosan fabrication agreement a potential leading indicator of a more sustained investment ramp rather than evidence of one already under way.

The session's gain needs to be read against persistent volatility. In November 2026, NuScale and Oklo had reportedly fallen roughly 15% in a week as rising bond yields weighed on the nuclear sector. That selloff came on the heels of a 7% gain in October when the Doosan manufacturing deal first circulated publicly. Wedbush's November 2026 initiation of nuclear sector coverage added a layer of sell-side caution: the firm assigned Buy ratings to Oklo and X-Energy while rating NuScale Underperform, a distinction pointing to lingering doubts about NuScale's commercial readiness relative to peers. Those doubts have company-specific anchors: a Romanian government audit published in September 2026 challenged the structure and delivery approach of NuScale's Doicești project, a material overhang on the company's international pipeline. At the same time, NuScale has accumulated operational milestones — first-of-kind safety-grade fuel pellet production in collaboration with MillenniTEK, a nuclear-specific AI tooling alliance with Nuclearn and NPX, and reported discussions with both the Tennessee Valley Authority and steelmaker Nucor around deployment scenarios — that speak directly to the AI data-center and industrial-power demand thesis underpinning most SMR valuations in this market.

For investors gauging NuScale from here, three developments warrant close attention. First, whether the TVA discussions — reported but not formalized as of the latest available coverage — produce a binding agreement; a signed letter of intent would materially validate the domestic deployment pipeline. Second, whether Wedbush or other cautious sell-side voices revise their Underperform stance as the Doosan fabrication schedule becomes publicly clearer — a ratings shift from a skeptical initiator carries more signal than reaffirmation from already-bullish analysts. Third, whether NuScale's quarterly capex run rate continues to accelerate beyond the $2M recorded in the quarter ended March 31, 2026; sustained growth in that figure would be the most direct observable evidence that the transition from development to physical production is proceeding in substance rather than in contractual form alone. The broader demand backdrop — hyperscalers and data-center operators seeking firm baseload power, European interest in SMR deployment, and an emergent nuclear-AI infrastructure narrative — remains constructive. But at $5.08, with no first module order announced, the distance between current market positioning and commercial execution remains the defining variable.